Skip to content

Measuring the Impact of Care in the Cognitive Behavioural Unit

Measuring the Impact of Care in the Cognitive Behavioural Unit

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03989245
Acronym
IMPACTUCC
Enrollment
588
Registered
2019-06-18
Start date
2020-01-20
Completion date
2025-12-31
Last updated
2024-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Disruptive Behaviour Disorders

Keywords

Severe disruptive behaviour disorders, Cognitive Behavioural Unit, Geriatric Follow-up and Rehabilitation Care Unit

Brief summary

The purpose of this study is to compare the rate of re-hospitalizations in relation to a disruptive behaviour disorder (at 3 and 6 months) between patients who have received care in Cognitive Behavioural Unity (UCC ) and those who have received care in Geriatric Follow-up and Rehabilitation Care Unit (SSR).

Detailed description

The purpose of this muliticentric non-interventional study is to compare the rate of re-hospitalization in relation to a disruptive behaviour disorder between patients receiving care in Cognitive Behavioural Unity UCC (target arm) and those who have received care in Geriatric Care Unit and Rehabilitation SSR (Control arm ). At Inclusion (Month 0) : Inclusion of patients admitted in UCC or in geriatric SSR units for less than 8 days after obtaining of their non opposition. Following data: Socio-educational Level, somatic and psychiatric comorbidities, classification of the type of dementia, evolution of nutritional status, biology (hemoglobin, creatinine, albuminemia), cognitive evaluation, treatment, pain assessment, assessment of disruptive behaviour disorders, discharge modalities, assistance plan, legal protection (before and after hospitalization), types of restraints, measurement of fall rates and their consequences, pathology and/or symptoms observed ( incidents) during hospitalization and vital status will be collected at inclusion and follow-up (1, 3 and 6 months ). At 1 month (M1), exit from hospitalization (M1): Data provided by Investigator . At 3 months (M3) and 6 months (M6) after discharge from hospital in UCC or SSR: Sponsor's Clinical Research Associateall call patient (or his legal representative) or to the primary caregiver or attending physician or EHPAD coordinating physician for collection of questionnaires.

Interventions

None listed

Sponsors

Gérond'if
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 70 ≥ years of age * Patient with severe disruptive behaviour disorders with a score (Frequency X Severity) \>7 to at least one of the 7 items targeted on Clinician Neuropsychaitric Inventury (NPI-Es) scale * Patient who was not cared for in Cognitive Behavioural Unit (UCC) within 6 months prior to admission * Patient entered center less than 8 days * Affiliation to a social security scheme * Patient or legal representative has expressed his non-opposition

Exclusion criteria

* 70 \< years of age * Patient with no score (FXG) \>7 to at least one of the 7 items targeted on Clinician Neuropsychaitric Inventury NPI-ES scale * Patient who was cared for in UCC within 6 months of admission * Entered Centre for 8 days or more * Not affiliated or entitled to a social security scheme * Patient or legal representative has expressed his opposition

Design outcomes

Primary

MeasureTime frame
Compare the rate of re-hospitalizations in relation to a disruptive behaviour disorder according Clinician Neuropsychaitric Inventury (NPI-Es) scaleaccording6 months

Secondary

MeasureTime frame
Measuring cognitive impairment according Mini-Mental State Examination (MMSE) score6 months
Screening for a nutritional disorder according Body Mass Index (BMI) score1 month
Assessment of somatic-comorbidities according Charlson scale6 months

Countries

France

Contacts

Primary ContactIsabelle Dufour
isabelle.dufour@gerondif.org+33 (0) 185781010
Backup ContactPrisca Lucas, PhD
prisca.lucas@gerondif.org+33 (0) 185781010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026